“deals” Archives

in
Entry Author Date Location
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down 12/03/19 Seattle
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer 12/03/19 National
Neurocrine Inks $50M Xenon Pharma Deal to Expand Into Epilepsy 12/02/19 San Diego
IFM Lands $55.5M to Launch NewCo Quattro and Discovery Incubator 12/02/19 Boston
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says 11/29/19 National
Ferring and Blackstone Team Up to Fund Gene Therapy Firm With $570M 11/25/19 Boston
Five Questions With a16z’s Vijay Pande on AI and Making New Drugs 11/25/19 National
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B 11/25/19 New York
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biopharma Execs Remain Optimistic Despite Political Headwinds 11/20/19 National
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin 11/18/19 Boston
Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology 11/14/19 Boston
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test 11/07/19 Boston
Arkuda Unveils $44M and a Protein Restoration Approach to Dementia 11/07/19 Boston
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund 11/06/19 National
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis 11/06/19 Boston
Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal 11/04/19 Detroit Ann Arbor
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug 10/31/19 Boston
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer 10/28/19 New York
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer 10/21/19 Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More 10/18/19 National
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs 10/17/19 National
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms 10/16/19 Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug 10/15/19 Boston
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma 10/10/19 Boston
Page 1 of 293 next page »